BSJP Performance — Invesco BulletShares 2025 High Yield Corporate Bond ETF
Data updated: 2026-01-29
BSJP returned +4.79% over one year to Nov 2025. Annualised returns are +7.65% over 3 years and +4.70% over 5 years. The fund trailed its Trading - Leveraged category average: $100 invested three years ago grew to $125, against $155 for the category, and to $105 over one year, against $121. Volatility over the past three years was 2.14% a year. In the 12 months to Nov 2025 the fund lost a net $424.7M, and assets reached $585.71M.
BSJP Growth of $100
What $100 invested in Invesco BulletShares 2025 High Yield Corporate Bond ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Leveraged category average over the same months.
| Period | BSJP | Category average |
|---|---|---|
| 1 year (Dec 2024 – Nov 2025) | $105 | $121 |
| 3 years (Dec 2022 – Nov 2025) | $125 | $155 |
| 5 years (Dec 2020 – Nov 2025) | $126 | $150 |
| Since data start (Sep 2019 – Nov 2025) | $133 | $160 |
BSJP Trailing Returns
Total returns to Nov 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +4.79% |
| 3 years (annualised) | +7.65% |
| 5 years (annualised) | +4.70% |
BSJP Annual Returns
Calendar-year total returns of Invesco BulletShares 2025 High Yield Corporate Bond ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Nov) | +4.41% |
| 2024 | +7.99% |
| 2023 | +10.87% |
| 2022 | −5.29% |
| 2021 | +4.57% |
| 2020 | +4.28% |
| 2019 (Sep–Dec) | +2.97% |
BSJP Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +0.6% | +0.5% | +0.3% | +0.4% | +0.5% | +0.4% | +0.4% | +0.4% | +0.3% | +0.4% | +0.2% | — |
| 2024 | +0.9% | +0.8% | +0.8% | +0.3% | +0.8% | +0.4% | +0.7% | +0.9% | +0.7% | +0.5% | +0.6% | +0.4% |
| 2023 | +2.4% | 0.0% | +0.5% | +1.0% | −0.1% | +1.3% | +1.1% | +0.8% | 0.0% | −0.8% | +2.4% | +1.7% |
| 2022 | −1.5% | −0.2% | −0.2% | −1.9% | +0.3% | −5.2% | +4.2% | −1.2% | −2.1% | +2.0% | +0.9% | −0.2% |
| 2021 | +0.1% | +0.5% | +0.6% | +0.9% | +0.3% | +0.8% | 0.0% | +0.3% | +0.1% | −0.1% | −0.6% | +1.5% |
| 2020 | −0.4% | −1.7% | −11.0% | +3.5% | +4.6% | +0.5% | +4.3% | +0.9% | −0.8% | +0.5% | +3.2% | +1.6% |
| 2019 | — | — | — | — | — | — | — | — | +0.4% | +0.2% | +0.4% | +2.0% |
BSJP Risk
Risk measures from monthly returns over Dec 2022 – Nov 2025.
- 3-year volatility (annualised): 2.14%
- 3-year Sharpe ratio: 1.47 (vs 4.5% risk-free rate)
- Best month: +2.40% (Nov 2023)
- Worst month: −0.75% (Oct 2023)
BSJP Fund Flows
Monthly money in and out of Invesco BulletShares 2025 High Yield Corporate Bond ETF, from SEC Form N-PORT.
- 12-month net flow: −$424.7M
- 12-month gross sales (incl. reinvestments): $64.6M
- Sales ÷ redemptions: 0.13×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Nov 2025 | $0 | $48.5M | −$48.5M |
| Oct 2025 | $0 | $36.9M | −$36.9M |
| Sep 2025 | $0 | $41.6M | −$41.6M |
| Aug 2025 | $0 | $64.7M | −$64.7M |
| Jul 2025 | $0 | $76.2M | −$76.2M |
| Jun 2025 | $0 | $85.5M | −$85.5M |
| May 2025 | $0 | $20.8M | −$20.8M |
| Apr 2025 | $16.1M | $50.6M | −$34.5M |
| Mar 2025 | $0 | $6.9M | −$6.9M |
| Feb 2025 | $18.5M | $6.9M | $11.6M |
| Jan 2025 | $2.3M | $27.7M | −$25.4M |
| Dec 2024 | $27.7M | $23.1M | $4.6M |
BSJP Assets Under Management
Net assets of Invesco BulletShares 2025 High Yield Corporate Bond ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-11-30 | $585.71M |
| 2025-08-31 | $713.29M |
| 2025-05-31 | $939.55M |
| 2025-02-28 | $1.00B |
| 2024-11-30 | $1.01B |
| 2024-08-31 | $1.03B |
| 2024-05-31 | $940.09M |
| 2024-02-29 | $776.22M |
| 2023-11-30 | $1.03B |
| 2023-08-31 | $1.14B |
| 2023-05-31 | $493.12M |
| 2023-02-28 | $471.62M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.